Abstract 1552: Isothiocyanates suppress human lung cancer cells metastasis
huiqin yan,yu zhu,xiang wu,boning liu,ying li,yunde liu,qinghua zhou,ke xu
DOI: https://doi.org/10.1158/1538-7445.AM10-1552
IF: 11.2
2010-01-01
Cancer Research
Abstract:Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC
Lung cancer is one of the most aggressive cancer types, and is the leading cause of cancer-related deaths worldwide. Metastasis is of great importance to the clinical management of cancer since it causes 90% of deaths from solid tumours. Therefore the development of novel anti-metastasis drugs becomes one of the most active fields in cancer research. Isothiocyanates are natural compounds found in consumable cruciferous vegetables. They have been shown to have the ability to inhibit chemical carcinogenesis by a wide variety of chemical carcinogens in animal models, inhibiting tumorigenesis in the lung, stomach, colon, liver, etc. Recent studies have also shown that isothiocyanates have antitumor activity, inhibiting several types of cultured human cancer cells growth, such as leukemia, prostate cancer and breast cancer. Our previous study also showed that isothiocyanates inhibit human lung cancer A549 cell growth. In the present study, we investigated the inhibitory effects of isothiocyanates on human lung cancer cell metastasis. We established a high-metastatic human large cell lung cancer cell line L9981, and found that both benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC) inhibited L9981 cells growth in a dose-dependent manner, the IC50 values were 5.0±0.22 μM and 9.7±0.39 μM, respectively. Apoptosis was induced at 20 μM after 24 h. Transwell migration assay showed that the metastatic abilities of L9981 cells were suppressed by 96%, and metastasis-correlated genes were modulated. Cell cycle was arrested at G2/M phase. BITC and PEITC treatment resulted in reactive oxygen species (ROS) accumulation and severe glutathione (GSH) depletion. Akt activation was diminished. At transcription level, both nuclear transcription factors NFκB and AP-1 activities were suppressed. NFκB activities were reduced to 28.8% and 68.5% by BITC and PEITC, respectively; AP-1 activities were reduced to 17.8% and 80.9% by BITC and PEITC, respectively. Our results showed that BITC and PEITC suppress human lung cancer cells metastasis by induction of apoptosis, modulation of metastasis correlated gene expression, and induction of oxidative stress. This study indicates the potential use of isothiocyanates in treatment of advanced lung cancer. The signal transduction pathways and validation of cellular therapeutic targets of these isothiocyanates are under investigation.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 1552.